{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T15:20:38Z","timestamp":1786548038385,"version":"build-2736575974"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,12]]},"DOI":"10.7759\/cureus.114418","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:20:56Z","timestamp":1786544456000},"source":"Crossref","is-referenced-by-count":0,"title":["Remote Adolescent-Onset Chorea Preceding Thrombotic Antiphospholipid Syndrome: A Case Report"],"prefix":"10.7759","author":[{"given":"Julian Andr\u00e9s","family":"Guti\u00e9rrez Baquero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Alejandra","family":"Prieto Zambrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Garz\u00f3n Sutach\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera R","year":"2002","unstructured":"Cervera R, Piette JC, Font J, et al.. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002, 46:1019-27. 10.1002\/art.10187","journal-title":"Arthritis Rheum"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-013-1023-z","article-title":"Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome","volume":"120","author":"Baizabal-Carvallo JF","year":"2013","unstructured":"Baizabal-Carvallo JF, Bonnet C, Jankovic J. Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome. J Neural Transm (Vienna). 2013, 120:1579-89. 10.1007\/s00702-013-1023-z","journal-title":"J Neural Transm (Vienna)"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/0961203309106832","article-title":"The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe","volume":"18","author":"Cervera R","year":"2009","unstructured":"Cervera R, Boffa MC, Khamashta MA, Hughes GR. The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe. Lupus. 2009, 18:889-93. 10.1177\/0961203309106832","journal-title":"Lupus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-224609","article-title":"2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"82","author":"Barbhaiya M","year":"2023","unstructured":"Barbhaiya M, Zuily S, Naden R, et al.. 2023 ACR\/EULAR antiphospholipid syndrome classification criteria. Ann Rheum Dis. 2023, 82:1258-70. 10.1136\/ard-2023-224609","journal-title":"Ann Rheum Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199705000-00006","article-title":"Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature","volume":"76","author":"Cervera R","year":"1997","unstructured":"Cervera R, Asherson RA, Font J, Tikly M, Pallar\u00e9s L, Chamorro A, Ingelmo M. Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature. Medicine (Baltimore). 1997, 76:203-12. 10.1097\/00005792-199705000-00006","journal-title":"Medicine (Baltimore)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-011-2120-7","article-title":"Chorea in primary antiphospholipid syndrome is associated with rheumatic fever","volume":"32","author":"Appenzeller S","year":"2012","unstructured":"Appenzeller S, Yeh S, Maruyama M, Barros SM, de Carvalho JF. Chorea in primary antiphospholipid syndrome is associated with rheumatic fever. Rheumatol Int. 2012, 32:2857-61. 10.1007\/s00296-011-2120-7","journal-title":"Rheumatol Int"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-009-8154-x","article-title":"The pathogenesis of neural injury in animal models of the antiphospholipid syndrome","volume":"38","author":"Katzav A","year":"2010","unstructured":"Katzav A, Shoenfeld Y, Chapman J. The pathogenesis of neural injury in animal models of the antiphospholipid syndrome. Clin Rev Allergy Immunol. 2010, 38:196-200. 10.1007\/s12016-009-8154-x","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.13432","article-title":"Antiphospholipid-related chorea: two case reports and role of metabolic imaging","volume":"9","author":"Lerjefors L","year":"2022","unstructured":"Lerjefors L, Andretta S, Bonato G, Mainardi M, Carecchio M, Antonini A. Antiphospholipid-related chorea: two case reports and role of metabolic imaging. Mov Disord Clin Pract. 2022, 9:516-21. 10.1002\/mdc3.13432","journal-title":"Mov Disord Clin Pract"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/03009749950155535","article-title":"Chorea in juvenile primary antiphospholipid syndrome. Reversible decreased circulation in the basal ganglia visualised by single photon emission computed tomography","volume":"28","author":"Nordal EB","year":"1999","unstructured":"Nordal EB, Nielsen J, Marhaug G. Chorea in juvenile primary antiphospholipid syndrome. Reversible decreased circulation in the basal ganglia visualised by single photon emission computed tomography. Scand J Rheumatol. 1999, 28:324-7. 10.1080\/03009749950155535","journal-title":"Scand J Rheumatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/614591","article-title":"Rheumatic fever associated with antiphospholipid syndrome: systematic review","volume":"2014","author":"da Silva F","year":"2014","unstructured":"da Silva F, de Carvalho J. Rheumatic fever associated with antiphospholipid syndrome: systematic review. J Immunol Res. 2014, 2014:614591. 10.1155\/2014\/614591","journal-title":"J Immunol Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.080268","article-title":"Antiphospholipid antibody-associated chorea","volume":"35","author":"Orzechowski NM","year":"2008","unstructured":"Orzechowski NM, Wolanskyj AP, Ahlskog JE, Kumar N, Moder KG. Antiphospholipid antibody-associated chorea. J Rheumatol. 2008, 35:2165-70. 10.3899\/jrheum.080268","journal-title":"J Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205663","article-title":"The estimated frequency of antiphospholipid antibodies in young adults with cerebrovascular events: a systematic review","volume":"74","author":"Sciascia S","year":"2015","unstructured":"Sciascia S, Sanna G, Khamashta MA, Cuadrado MJ, Erkan D, Andreoli L, Bertolaccini ML. The estimated frequency of antiphospholipid antibodies in young adults with cerebrovascular events: a systematic review. Ann Rheum Dis. 2015, 74:2028-33. 10.1136\/annrheumdis-2014-205663","journal-title":"Ann Rheum Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.40.8.1190","article-title":"Antiphospholipid antibodies and cerebral ischemia in young people","volume":"40","author":"Brey RL","year":"1990","unstructured":"Brey RL, Hart RG, Sherman DG, Tegeler CH. Antiphospholipid antibodies and cerebral ischemia in young people. Neurology. 1990, 40:1190-6. 10.1212\/wnl.40.8.1190","journal-title":"Neurology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/17474930221150349","article-title":"Antiphospholipid syndrome, antiphospholipid antibodies, and stroke","volume":"18","author":"Mittal P","year":"2023","unstructured":"Mittal P, Quattrocchi G, Tohidi-Esfahani I, Sayar Z, Chandratheva A, Cohen H. Antiphospholipid syndrome, antiphospholipid antibodies, and stroke. Int J Stroke. 2023, 18:383-91. 10.1177\/17474930221150349","journal-title":"Int J Stroke"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2025-006014","article-title":"2023 ACR\/EULAR classification criteria for antiphospholipid syndrome: more lights rise but shade remains","volume":"11","author":"Alijotas-Reig J","year":"2025","unstructured":"Alijotas-Reig J, Miro-Mur F, Hoxha A, Khamashta MA, Shoenfeld Y. 2023 ACR\/EULAR classification criteria for antiphospholipid syndrome: more lights rise but shade remains. RMD Open. 2025, 11:e006014. 10.1136\/rmdopen-2025-006014","journal-title":"RMD Open"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215213","article-title":"EULAR recommendations for the management of antiphospholipid syndrome in adults","volume":"78","author":"Tektonidou MG","year":"2019","unstructured":"Tektonidou MG, Andreoli L, Limper M, et al.. EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis. 2019, 78:1296-304. 10.1136\/annrheumdis-2019-215213","journal-title":"Ann Rheum Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/524318-remote-adolescent-onset-chorea-preceding-thrombotic-antiphospholipid-syndrome-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T14:20:57Z","timestamp":1786544457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/524318-remote-adolescent-onset-chorea-preceding-thrombotic-antiphospholipid-syndrome-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.114418","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,12]]}}}